Revised recommendations reflect new findings, including recent reports on dual antiplatelet therapy and timeliness of reperfusion.
Sponsoring Organizations: American College of Cardiology and the American Heart Association, in collaboration with the Canadian Cardiovascular Society and endorsed by the American Academy of Family PhysiciansBackground and Purpose: Results of recent studies and other clinical information have prompted this focused update of the 2004 ACC/AHA guidelines for managing ST-segment-elevation MI (STEMI). Evidence from studies enrolling large numbers of subjects outside North America were found to be relevant, although the authors acknowledge that a number of factors might influence the individual treatment effect in different populations.
Key Points:
1. The recommendations for the use of intravenous beta-blockers within 24 hours of STEMI now specify …
Reviewing Author
DisclosuresLeadership positions in
professional societiesBern Heart Foundation (President); International Academy of Medicine, Bern, Switzerland (Director)
DisclosuresLeadership positions in
professional societiesBern Heart Foundation (President); International Academy of Medicine, Bern, Switzerland (Director)